The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Voriconazole Teva 200 mg film-coated tablets

Teva Pharma B.V.PA0749/181/001

Main Information

Trade NameVoriconazole Teva 200 mg film-coated tablets
Active SubstancesVoriconazole
Dosage FormFilm-coated tablet
Licence HolderTeva Pharma B.V.
Licence NumberPA0749/181/001

Group Information

ATC CodeJ02AC Triazole derivatives
J02AC03 voriconazole


License statusAuthorised
Licence Issued23/08/2013
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Educational Materials - HCP

Educational Materials - Patient

Generics Information

Interchangeable List CodeIC0146-067-003
Interchangeable List DocumentPDF of Interchangeable List
« Back